Sequana Medical announces 2022 Full Year Results and 2023
PRESS RELEASEREGULATED INFORMATION09 February 2023, 07:00 CEST alfapump® – successful primary endpoint read-out of North American pivotal POSEIDON study...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-02-09, 13:07
